Archive > Volume 29 Issue 12 > 2022,29(12):1130-1135. DOI:10.3872/j.issn.1007-385X.2022.12.010 Prev Next

Review

Implications of cis-PD-L1: CD80 interactions on cancer immunotherapy

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.